BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto Study

2018

Fasching, Peter A.

Loibl, Sibylle

Hu, Chunling

Hart, Steven N.

Shimelis, Hermela

et al.

Wissenschaftlicher Artikel

Journal of Clinical Oncology ; 36 (2018), 22. - S. 2281+. - ISSN 0732-183X. - eISSN 1527-7755

UKU. Comprehensive Cancer Center Ulm (CCCU)

[DDC Sachgruppe]: DDC 610 / Medicine & health